retatrutide type 1 diabetes Retatrutide—A Game Changer in Obesity Pharmacotherapy Eli Lilly's retatrutide shows promising

The phase 2 trial data shows that fatigue rates varied more by titration speed than by final dose

Leveraging large-scale biobank EHRs to enhance pharmacogenetics of cardiometabolic disease medications

The only things standing in its way of making history are its ongoing Phase 3 trials, the coveted stamp of approval from the FDA, and possibly upcoming competitors in the clinical pipeline

When you eat these foods, they pass through your upper GI tract undigested and reach the colon where they feed the exact bacterial strains that promote healthy motility

How much will Retatrutide cost

GLP-1 drugs are not without side effects